Trial Profile
Clinical Trial to Evaluate ET-01 in Subjects With Lateral Canthal Lines
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Therapeutic Use
- Sponsors Eirion Therapeutics
- 07 Feb 2019 Status changed from active, no longer recruiting to completed.
- 07 Aug 2018 Planned End Date changed from 1 Jul 2018 to 1 Nov 2018.
- 07 Aug 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Aug 2018.